In-Vitro Diagnostics
In-Vitro Diagnostics require high-precision methods of analysis and perfectly packed consumables. We help you to help others.
Do you manufacture consumables for In-Vitro Diagnostics? Are you running an industrial production plant for highly complex products? Would you like to get a firmer grip on costs and turnaround times to become more competitive? Rychiger would be delighted to assist you in achieving your goals.
As your partner, we work closely with you – from the initial draft of your production concept to the industrialization of your processes. We were the first machine manufacturer in the world to come up with a design language optimized for molecular diagnostics.
In-Vitro Diagnostics (IVD) are a growth market and save lives. More and more people all over the world benefit from IVD as it makes it easy to detect and treat diseases, offering many advantages over conventional diagnostics. With great opportunity comes great responsibility.
From manual pathogen-specific tests to syndromic testing
We work with you to realize technologies for what can be done today – and for what will become possible in the near future. Modern IVD methods do away with time-consuming manual work in labs, as more and more tests are now fully automated and can even be performed directly at the point of care.
Real-time PCR kits for instance detect the presence of specific antigens, and are also suitable for syndromic testing. This method enables medics to test for a broad array of pathogens associated with a particular syndrome in one single process. PCR kits are commonly used in connection with respiratory infections, gastroenteritis, hepatitis, meningitis or HIV. Other fields where syndromic testing is particularly useful are sexually transmitted diseases, tropical medicine and pediatrics. Today, syndromic testing methods are already able to detect more than 140 viruses, bacteria, parasites and fungi. These tests are quicker and safer than lab procedures, as they eliminate the risk of cross-contamination.
A syndromic PCR test detects bacteria or viruses in a sample within hours rather than days, as would be the case with conventional methods. And they are even successful where the pathogen is hard to cultivate. Syndromic testing boosts patient satisfaction, as they can shorten their stay in hospital and do not need to undergo potentially unnecessary antibiotic treatment.